Press "Enter" to skip to content

New patent expiration for Allergan drug AVYCAZ

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug AVYCAZ

Annual Drug Patent Expirations for AVYCAZ
Annual Drug Patent Expirations for AVYCAZ

Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has one hundred and eigthy patent family members in fifty-four countries.

The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug AVYCAZ
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions